LOS ANGELES, Nov. 27, 2023 (GLOBE NEWSWIRE) -- Irwin Naturals Inc. (CSE: IWIN) (OTC: IWINF) (FRA: 97X) (“Irwin” or the “Company”) reported its financial results for its third quarter of fiscal 2023, the period ended September 30, 2023, on www.sedar.com. Financial Highlights for Q3 2023 Q3 revenue was $19.1 million, down 13.4% from $22.0 million in Q3 2022. Income from operations decreased $2.9 million from $0.6 million in Q3... Read More

LOS ANGELES, Aug. 28, 2023 (GLOBE NEWSWIRE) -- Irwin Naturals Inc. (CSE: IWIN) (OTC: IWINF) (FRA: 97X) (“Irwin” or the “Company”) reported its financial results for its second quarter of fiscal 2023, the period ended June 30, 2023, on www.sedar.com. Financial Highlights for Q2 2023 Q2 revenue was $22.1 million, up 1.5% from $21.8 million in Q2 2022. Income from operations decreased $2.4 million from $0.5 million in Q2 2022... Read More

LOS ANGELES, July 28, 2023 (GLOBE NEWSWIRE) -- Irwin Naturals Inc. (CSE: IWIN) (OTC: IWINF) (FRA: 97X) (“Irwin” or the “Company”) a leading innovator in natural health products, is catapulting into the California cannabis market with its line of Power to Sleep, Get Lit, and Balance tinctures through a licensing and supply agreement with The Hive Laboratory, LLC ("The Hive”) as announced previously . Available now for... Read More

LOS ANGELES, May 31, 2023 (GLOBE NEWSWIRE) -- Irwin Naturals Inc. (CSE: IWIN) (OTC: IWINF) (FRA: 97X) (“Irwin” or the “Company”) today reported its financial results for the first quarter and year ended March 31, 2023, on www.sedar.com. Financial Highlights for Q1 2023 (all comparisons are for the year ended December 31 unless otherwise indicated): Q1 2023 revenue was $22.5 million, down 0.4% from $22.6 million in Q1 2022.... Read More

LOS ANGELES, May 25, 2023 (GLOBE NEWSWIRE) -- Irwin Naturals Inc. (CSE: IWIN) (OTC: IWINF) (FRA: 97X) (“Irwin” or the “Company”) today reported its financial results for the fourth quarter and year ended December 31, 2022, on www.sedar.com. Financial Highlights for FY 2022 (all comparisons are for the year ended December 31 unless otherwise indicated): Annual revenue was $89.5 million, down 10.8% from $100.3 million in 2021.... Read More

LOS ANGELES, May 02, 2023 (GLOBE NEWSWIRE) -- Irwin Naturals Inc. (CSE: IWIN) (OTC: IWINF) (FRA: 97X) (“Irwin” or the “Company”) announces that the British Columbia Securities Commission has issued a failure-to-file-cease trade order (“ CTO ”) pursuant to National Policy 11-207 – Failure to File Cease Trade Orders and Revocations in Multiple Jurisdictions in respect of the securities of the Company as a result of the Company... Read More

LOS ANGELES, March 24, 2023 (GLOBE NEWSWIRE) -- Irwin Naturals Inc. (CSE: IWIN) (OTC: IWINF) (FRA: 97X) (“Irwin” or the “Company”), is proud to announce the release of Irwin Naturals Cannabis’ new CBD 25mg Softgels in Canada, available nationwide through the Starseed Medicinal Medical Group platform. CBD 25mg Softgels are just... Read More

LOS ANGELES, March 21, 2023 (GLOBE NEWSWIRE) -- Irwin Naturals Inc. (CSE: IWIN) (OTC: IWINF) (FRA: 97X) (“Irwin” or the “Company”) is thrilled to announce the successful acquisition of Keta Media, LLC, dba Ketamine Media (“Ketamine Media”) as of March 17, 2023. Ketamine Media is the nation's foremost advertising company dedicated to raising awareness about the clinical use of ketamine. The agreement with Ketamine Media was... Read More

LOS ANGELES, March 16, 2023 (GLOBE NEWSWIRE) -- Irwin Naturals Inc. (CSE: IWIN) (OTC: IWINF) (FRA: 97X) (“Irwin” or the “Company”), announced today that it has terminated the non-binding amended and restated letter of intent ("LOI") for a business combination with Braxia Scientific Corp. ("Braxia"), (the "Proposed Transaction"). The Company's news release dated January 27, 2023, contained full details of the Proposed... Read More

Braxia Health ketamine treatments up 29% YoY in Q3 2023 and revenue up 50.5% YoY Toronto, Ontario--(Newsfile Corp. - March 1, 2023) - Braxia Scientific Corp. (CSE: BRAX) (OTC Pink: BRAXF) (FSE: 4960), ("Braxia Scientific", or the "Company"), a medical research and telemedicine company with clinics providing innovative ketamine and psilocybin treatments for depression and related disorders, today announced the filing of its... Read More

LOS ANGELES, Feb. 17, 2023 (GLOBE NEWSWIRE) -- Irwin Naturals Inc. (CSE: IWIN) (OTC: IWINF) (FRA: 97X) (“Irwin” or the “Company”) is pleased to announce the Company has successfully completed the acquisition of Serenity Health, LLC, (“Serenity”) one of the leading ketamine clinics in Louisville, KY. The agreement with Serenity was initially announced November, 30, 2022. The acquisition, completed on February 16, 2023, marks... Read More

LOS ANGELES, Feb. 02, 2023 (GLOBE NEWSWIRE) -- Irwin Naturals Inc. (CSE: IWIN) (OTC: IWINF) (FRA: 97X) (“Irwin” or the “Company”) announced today that the Company has secured a credit facility as of February 1, 2023 with its existing commercial lender for up to $60 million with $40 million of it currently committed. The rate shall be variable based on the margins of the credit facilities. Half of the facility is in place... Read More

Strategic transaction assembles an experienced management and scientific team world-renowned in the mental health treatment, research and development. Establishes large footprint of 17 specialized mental health clinics across North America, and 5 more under definitive agreement with Irwin Naturals, enhanced by a telehealth platform expected to extend access to critical treatments for millions of people across multiple states... Read More

LOS ANGELES, Jan. 26, 2023 (GLOBE NEWSWIRE) -- Irwin Naturals Inc. (CSE: IWIN) (OTC: IWINF) (FRA: 97X) (“Irwin” or the “Company”) announced today a licensing agreement with a partner in Oklahoma to produce and distribute Irwin Naturals THC products. Klee Irwin, CEO of Irwin Naturals said, “Oklahoma is a significant step in what is becoming a sprint to put Irwin Naturals THC products on the shelves of dispensaries in all 38... Read More

LOS ANGELES, Jan. 10, 2023 (GLOBE NEWSWIRE) -- Irwin Naturals Inc. (CSE: IWIN) (OTC: IWINF) (FRA: 97X) (“Irwin” or the “Company”) , is proud to announce it has signed a Letter of Intent entering into a partnership with Braxia Scientific Corp. (“Braxia Scientific”), (CSE: BRAX) (OTC: BRAXF) (FWB: 4960), a medical research company providing psychiatric, innovative ketamine and psilocybin treatments for mental health disorders,... Read More

LOS ANGELES, Dec. 21, 2022 (GLOBE NEWSWIRE) -- Irwin Naturals Inc. (CSE: IWIN) (OTC: IWINF) (FRA: 97X) (“Irwin” or the “Company”) announced on a licensing agreement with JV 805 LLC dba Hyphae Wellness (“Hyphae Wellness”), one of Oregon’s premier mushroom and cannabis product developers, to manufacture, sublicense and distribute Irwin Naturals THC products throughout that state. Klee Irwin, CEO of Irwin Naturals, said, “We’re... Read More

LOS ANGELES, Dec. 09, 2022 (GLOBE NEWSWIRE) -- Irwin Naturals Inc. (CSE: IWIN) (OTC: IWINF) (FRA: 97X) (“Irwin” or the “Company”) completed the acquisition of the assets of Clare Clinic, Inc., d/b/a Florida Mind Health Center. The Company entered into an acquisition agreement (the “Agreement”) dated October 30, 2022 with Clare Clinic, Inc., d/b/a Florida Mind Health Center, which serves clients out of three healthcare... Read More

Successful Execution on Ketamine Clinic Rollup Strategy and Cannabis Licensing to Accelerate Future Growth LOS ANGELES, Dec. 05, 2022 (GLOBE NEWSWIRE) -- Irwin Naturals Inc. (CSE: IWIN) (OTC: IWINF) (FRA: 97X) (“Irwin” or the “Company”) announced the Company filed results for its third quarter of fiscal 2022, the period ended September 30, 2022 on www.sedar.com . Sean Sand, CFO, stated, “Despite cost pressures continuing... Read More

LOS ANGELES, Nov. 30, 2022 (GLOBE NEWSWIRE) -- Irwin Naturals Inc. (CSE: IWIN) (OTC: IWINF) (FRA: 97X) (“Irwin” or the “Company”) announced today it reached a binding, arms-length, agreement to acquire Serenity Health , LLC in Louisville, Kentucky, on November 25, 2022. The move continues Irwin’s national ketamine clinic rollup strategy that has seen the Company move quickly toward its goal of building Irwin Naturals... Read More

LOS ANGELES, Nov. 09, 2022 (GLOBE NEWSWIRE) -- Irwin Naturals Inc. (CSE: IWIN) (OTC: IWINF) (FRA: 97X) (“Irwin” or the “Company”) has reached a binding, arm’s length agreement to acquire the assets of Tri-Cities Infusion & Wellness Clinic, PLLC on November 5, 2022 which is located in Kennewick, Washington. This will be the first facility in Washington for Irwin Naturals Emergence, a fast-growing national chain of psychedelic... Read More

Irwin Naturals Inc. (CSE: IWIN) (OTC: IWINF) (FRA: 97X) (“Irwin” or the “Company”) announced today a licensing and supply agreement with Mockingbird Cannabis, LLC (“Mockingbird Cannabis”) to produce and distribute Irwin Naturals THC products in Mississippi. Klee Irwin, CEO of Irwin Naturals said, “For 28 years, we have safely cared for the health of our customers, and we look forward to being the trusted friend on the... Read More

Irwin Naturals Inc. (CSE: IWIN) (OTC: IWINF) (FRA: 97X) (“Irwin” or the “Company”) entered into a binding agreement on October 30, 2022, to acquire the assets of Clare Clinic, Inc., d/b/a Florida Mind Health Center, which operates three healthcare clinics in Florida. The clinics are located in Gainesville, Tallahassee and Panama City, and offer ketamine-assisted therapy , NAD+ and other IV therapies . Those clinics will join... Read More

Irwin Naturals Inc. (CSE: IWIN) (OTC: IWINF) (FRA: 97X) (“Irwin” or the “Company”) has reached a binding agreement to acquire Dura Medical, LLC, a clinic in Naples, Florida, which offers ketamine-infusion therapy among its options for cutting-edge treatment of mental health disorders. The clinic will be incorporated into Irwin Naturals Emergence, a fast-growing national chain offering psychedelic mental healthcare that... Read More

Irwin Naturals Inc. (CSE: IWIN) (OTC: IWINF) (FRA: 97X) (“Irwin” or the “Company”) has reached a binding agreement on September 30, 2022 to acquire Ketamine Infusions of Idaho, PLLC, which operates a clinic in Idaho Falls. The clinic will join Irwin Naturals Emergence, a fast-growing national chain of psychedelic mental-health clinics, which already has deals to add a total of 11 clinics across six different states. This... Read More

Irwin Naturals Inc. (CSE: IWIN) (OTC: IWINF) (FRA: 97X) (“Irwin” or the “Company”) today announced a definitive agreement to purchase all of the issued and outstanding shares of Keta Media, LLC dba Ketamine Media (“Ketamine Media”), the nation’s leading growth platform for clinics offering ketamine-assisted therapy. With a global network dedicated to improving patient outcomes, KM has established relationships with clinics... Read More

Irwin Naturals Inc. (CSE: IWIN) (OTC: IWINF) (FRA: 97X) (“Irwin” or the “Company”) announced today its intention to commence a normal course issuer bid (“NCIB”), under which the Company may purchase up to 75,466 of the Company’s Subordinate Voting Shares (“SVS” or “Shares”) over a 12-month period, representing approximately 5% of its issued and outstanding SVS as of September 26, 2022. The Company is pursuing an NCIB because... Read More

Irwin Naturals Inc. (CSE: IWIN) (OTC: IWINF) (FRA: 97X) (“Irwin” or the “Company”) announced today that it has entered into a binding to agreement to acquire all of the membership interests in Happier You, LLC, which operates a ketamine clinic in central Ohio. This clinic will be added to Irwin Naturals Emergence, a fast-growing national chain of psychedelic mental-health clinics that has previously acquired 10 different... Read More

Irwin Naturals Inc. (CSE: IWIN) (OTC: IWINF) (FRA: 97X) (“Irwin” or the “Company”) announced today a licensing agreement with 42 Degrees Processing LLC (“42 Degrees”), through its subsidiary Irwin Naturals Cannabis, Inc., to produce and distribute Irwin Naturals THC products in Michigan, one of the fastest-growing cannabis markets in the country. Klee Irwin, CEO of Irwin Naturals said, “Michigan is a significant step in what... Read More

Rapid Execution on Cannabis Licensing and Ketamine Clinic Rollup Strategy to Accelerate Future Growth Irwin Naturals Inc. (CSE: IWIN) (OTC: IWINF) (FRA: 97X) (“Irwin” or the “Company”) announced the Company filed results for its second quarter of fiscal 2022, the period ended June 30, 2022 on www.sedar.com . Philippe Faraut, CFO, stated, “While supply chain issues, reduced inventory at our customers and product transitions... Read More

Irwin Naturals Inc. (CSE: IWIN) (OTC: IWINF) (FRA: 97X) (“Irwin” or the “Company”) completed the acquisition of its first Vermont clinic, continuing what has been the rapid expansion of this nationally known brand name into the emerging field of psychedelic mental healthcare. Irwin Naturals Emergence previously acquired five ketamine clinics in Florida , one in Iowa ., one in New Hampshire, and two in Georgia. This... Read More

Irwin Naturals Inc. (CSE: IWIN) (OTC: IWINF) (FRA: 97X) (“Irwin” or the “Company”) completed the acquisition of two ketamine clinics in Georgia through an asset purchase of Invictus Clinics, LLC, which will be brought into the fast-growing national chain of psychedelic mental-health facilities. The clinics are located in Atlanta and Woodstock, Ga., operated under the name of the Invictus Clinic. They offer ketamine-assisted... Read More

Irwin Naturals Inc. (CSE: IWIN) (OTC: IWINF) (FRA: 97X) (“Irwin” or the “Company”), whose herbal supplements are already available in in 100,000 stores in North America, has reached a licensing agreement with Entourage Health Corp. (TSX-V:ENT) (OTCQX:ETRGF) (FSE:4WE), a Canadian producer and distributor of award-winning cannabis products, through its wholly owned subsidiary Irwin Naturals Cannabis, Inc. Under this exclusive... Read More

Irwin Naturals Inc. (CSE: IWIN) (OTC: IWINF) (FRA: 97X) (“Irwin” or the “Company”) completed the acquisition of the assets of New England Ketamine, which is located in Salem, New Hampshire and serves clients in six different states in the Northeast. This is the third acquisition that Irwin Naturals Emergence has completed in the past five months as it builds a national chain of mental-health clinics providing psychedelic... Read More

Irwin Naturals Inc. (CSE: IWIN) (OTC: IWINF) (FRA: 97X) (“Irwin” or the “Company”) will add to its rapidly growing chain of psychedelic mental health centers, announcing today that it has signed a definitive agreement to acquire two clinics in Georgia. Irwin has entered into a binding agreement to acquire 100% of the issued and outstanding membership interest in Invictus Clinic, LLC, a healthcare company operating clinics in... Read More

Irwin Naturals Inc. (CSE: IWIN) (OTC: IWINF) (FRA: 97X) (“Irwin” or the “Company”) announced today it has entered into a binding agreement to acquire the assets of Hobie Fuerstman D O PLC, doing business as Preventive Medicine (“Preventive”), a clinic operation based in Colchester, Vermont. Klee Irwin, CEO of Irwin Naturals, said, “Our roll-up is gathering momentum. This is the eighth ketamine clinic we are adding to our... Read More

Cannabis Licensing and Ketamine Clinic Rollup Strategy Accelerating Growth Company to host conference call Tuesday, May 31, 2022 at 2:00 pm EST Irwin Naturals Inc. (CSE: IWIN) (OTC: IWINF) (FRA: 97X) (“Irwin” or the “Company”) announced the Company filed results for its first quarter of fiscal 2022, the period ended March 31, 2022 on www.sedar.com . Philippe Faraut, CFO, stated, “Revenues were slightly impacted by supply... Read More

Irwin Naturals Inc. (CSE: IWIN) (OTC: IWINF) (FRA: 97X) (“Irwin” or the “Company”) announced today that Klee Irwin, CEO, will be presenting at the psychedelic Capital conference by Microdose. Following his successful speech at the Davos ’22 Medical Psychedelic Series, Klee Irwin will appear in a fireside interview with Microdose founder Patrick Moher. Tickets for the online event can be purchased at Microdose Psychedelic... Read More

Irwin Naturals Inc. (CSE: IWIN) (OTC: IWINF) (FRA: 97X) (“Irwin” or the “Company”) announced today it has licensed its brand to BeneLeaves Ltd, an Ohio manufacturer of cannabis products. BeneLeaves will produce and distribute formulas such as Irwin Naturals’ Power to Sleep with THC. Irwin’s CEO, Klee Irwin, said, “It is clear that the value of our highly trusted brand, known by over 100 million people**, is recognized by... Read More

Irwin Naturals Inc. (CSE: IWIN) (OTC: IWINF) (FRA: 97X) (“Irwin” or the “Company”) announced today that, further to its press release of April 18, 2022, the Company has completed the acquisition of KHC Capital Group, LLC. The Company entered into an acquisition agreement (the “ Agreement ”) dated April 17, 2022 with KHC Capital Group, LLC and related entities (“ Ketamine Health Centers ”), which owns a chain of five ketamine... Read More

Irwin Naturals Inc. (CSE: IWIN) (OTC: IWINF) (FRA: 97X) (“Irwin” or the “Company”) announced today it has licensed its brand to Larsen Group II LLC, a Colorado manufacturer of cannabis products. Larsen Group II LLC will produce and distribute formulas such as Irwin Naturals Power to Sleep with THC. Irwin’s CEO, Klee Irwin, said, “I’m pleased with how quickly our team is lining up distribution across the US in what is now... Read More

Irwin Naturals Inc. (CSE: IWIN) (OTC: IWINF) (FRA: 97X) (“Irwin” or the “Company”) announced today it has entered into a binding agreement to acquire the assets of New England Ketamine PLLC (“NEK”), a healthcare clinic in Salem, New Hampshire. Klee Irwin, CEO, said, “Adding another EBITDA positive ketamine clinic to our expanding footprint positions us well for accelerated growth of profitability. With over 100 clinics in... Read More

Irwin Naturals Inc. (CSE: IWIN) (OTC: IWINF) (FRA: 97X) (“Irwin” or the “Company”) announced today it has entered into an agreement through its wholly owned subsidiary Irwin Naturals Cannabis, Inc., with Assurance Laboratories, LLC (“Assurance”), a New Mexico based manufacturer and distributor of cannabis products, pursuant to which Assurance will license the Irwin Naturals brand, and will produce and distribute Irwin... Read More

Irwin Naturals Inc. (CSE: IWIN) (OTC: IWINF) (FRA: 97X) (“Irwin” or the “Company”) today announced the Company will file its results for the fiscal fourth quarter and full year 2021, the period ended December 31, 2021, on Tuesday May 3, 2022 on www.sedar.com . Conference call CEO Klee Irwin and CFO Philippe Faraut will be hosting a conference call that same day at noon (EST) to discuss the results, as well as the Company’s... Read More

Growth of Core Business Fueling Rollup of Psychedelic Mental Health Clinics Company to host conference call Tuesday May 3, 2022 at 2:00 pm EST Irwin Naturals Inc. (CSE: IWIN) (OTC: IWINF) (FRA: 97X) (“Irwin” or the “Company”) announced the Company filed results for the fiscal fourth quarter and the financial year ended December 31, 2021, on Monday May 2, 2022 on www.sedar.com . Financial Highlights (US$ '000s) FY 2021 Change... Read More

Irwin Naturals Inc. (CSE: IWIN) (OTC: IWINF) (FRA: 97X) (“Irwin,” “Irwin Naturals” or the “Company”) announced today it has entered into an agreement through its wholly owned subsidiary Irwin Naturals Cannabis, Inc., with The Hive Laboratory, LLC, (“The Hive”) a California manufacturer and distributor of cannabis products, pursuant to which The Hive will license the Irwin Naturals brand, and will produce and distribute Irwin... Read More